The replication of Moloney murine leukemia virus (MMuLV) in chronically infected mouse cells arrested at the GO/Gl phase of the cell cycle by different procedures was investigated. MMuLV production was inhibited in glutamine-and isoleucine (Gln-Ile)-deprived GO/Gl cells. In contrast, butyric acid treatment, which efficiently arrested the cells at the GO/Gl phase of the cell cycle, did not inhibit MMuLV production. Furthermore, the inhibition of MMuLV production caused by either Gln-Hle deprivation or by interferon (IFN) treatment was overcome by butyric acid treatment. Thus, the replication of MMuLV could be dissociated from cell proliferation. The inhibition of MMuLV production in Gln-lle-deprived cell cultures was compared to the inhibitory effect of IFN, which is known to affect budding and release of the virus. Rates 
The dependence of retrovirus replication on cell proliferation is a well-documented phenomenon. The productive infection of murine leukemia viruses (MuLV) is aborted in serum-starved, GO/Gl-phase-arrested cells both at the level of proviral DNA synthesis (11) and during virus production from the chronically infected cells (3, 10, 23, 27) . Although virus production is inhibited in the chronically infected GO/Gl-arrested cells, viral RNA and protein synthesis are unaffected (10, 27) . Release of the cells from GO/G1 arrest by the addition of serum results in a resumption of Moloney MuLV (MMuLV) production. Although complex patterns of virus regulation in the synchronized cultures have been observed, maximal MuLV production coincides with the M phase of the cell cycle (3, 10, 20, 23) .
The late stage at which virus replication is suppressed in the serum-starved GO/Gl cells is reminiscent of the inhibitory effect of interferon (IFN) on MuLV. It has been demonstrated by several investigators that, although the synthesis of MuLV RNA and proteins are uninterrupted in the IFN-treated mouse cells, budding and release of virions are blocked (1, 9, 25) . Whether the two treatments, IFN and growth arrest, affect the same level of MuLV replication is not known.
Parallel to the murine system, the production of avian sarcoma leukosis virus by infected chicken cells is suppressed in GO/Gl-arrested cultures maintained in serum-free medium (4, 16) . However, avian sarcoma leukosis virus is normally produced in GO/Gl-arrested cultures maintained in the presence of serum which was depleted of growth factors (4, 12) . Thus, it has been suggested by Bell et al. (4) that a compound in the serum distinct from growth factor may be required for avian sarcoma leukosis virus production.
In the present work, we investigated the replication of MuLV in mouse cells arrested at the GO/Gl phase by different procedures. The specific treatment, rather than the * Corresponding author.
arrest of the cell, appears to be critical for the virus replication.
MATERIALS AND METHODS
Cell cultures. JLSV11 cells (5 x 105 cells), BALB/c cells chronically infected with MMuLV (8), were seeded in 60-mm dishes with RPMI 1640 medium supplemented with 10% calf serum. After 24 h, the medium was changed, and duplicate cultures were treated with the various agents. Mouse IFN produced in L-cells was purified to a specific activity of 7 x 107 U/mg of protein (24). The IFN was added directly to the medium.
Butyric acid treatment. n-Butyric acid (Sigma Chemical Co.), a 0.1 M stock solution in minimal Eagle medium (MEM-E) without amino acids, was neutralized with NaOH to pH 7.0. Butyric acid from the stock was added to medium containing 10% calf serum to give a 5 mM final concentration.
Gln-Ile deprivation. MEM-E without glutamine and isoleucine (Gln-Ile) was supplemented with 5% dialyzed fetal calf serum. Before this medium was added, cultures were washed twice with the same medium without serum.
Reverse transcriptase assay. Growth medium (4 ml) was collected after 24 h and centrifuged at 5,000 x g for 20 min to remove cell debris, and virus was pelleted by centrifugation at 100,000 x g for 1 h. Virus was suspended in 100 ,ul of TNE (20 mM roacetic acid-insoluble material after 1-h pulse-labeling of the cultures (14) .
Analysis of MMuLV proteins. Cells in 90-mm plates were labeled with [35S]methionine (14 , Ci) in minimal essential medium without methionine (and without Gln-Ile in the amino acid-deprived cultures).
MMuLV proteins were immunoprecipitated from the radiolabeled cell extracts as described by Witte and Baltimore (31) . In brief, monolayer cells were lysed in extraction buffer (10 mM and the incubation was continued for an additional 2 h. The complexes were washed with the extraction buffer and prepared for sodium dodecyl sulfate-15% polyacrylamide gel electrophoresis. Specificity of the immunoprecipitation was checked in two control systems: (i) purified MMuLV virions out-competed the radiolabeled proteins; (ii) nonimmune rabbit sera precipitated no radioactive antigen from the cell extracts. Anti-MMuLV and anti-p30 rabbit sera were obtained from U. Olshevsky (13) .
RESULTS
MMuLV production in cells arrested by butyric acid treatment and Gln-Ile deprivation. Arrest of mouse cells at the GO/Gl phase by serum starvation resulted in the inhibition of MuLV production (10, 23) . To investigate the effect of other procedures which arrest the cell at a similar phase of the cell cycle but in the presence of serum, cultures were treated with butyric acid (6, 7, 15) or deprived of amino acids (22, 32) . The results (Fig. 1) indicate that proliferation of chronically infected mouse cells could be efficiently arrested after treatment for 48 h with butyric acid in a complete growth medium. Nonetheless, treatment with butyric acid enhanced the production of MMuLV measured by reverse transcriptase activity in the growth medium. In repeated experiments, the enhancement of MMuLV production per cell varied, but we did not observe MMuLV inhibition in the butyric acid-treated cultures. These results suggest, contrary to the general assumption, that MuLV production in chronically infected cells is not coupled with cell proliferation. To understand this unexpected observation, we compared MMuLV production after cell arrest by two independent procedures, namely butyric acid treatment and Gln-Ile deprivation. The latter procedure has previously been shown to arrest efficiently cells in the presence of serum at the GO/Gl phase of the cell cycle (22, 32) . Release of cells from butyric acid treatment or Gln-Ile deprivation resulted in a synchronic progression to the S phase of the cell cycle ( Fig.  2A ). Cell DNA synthesis was noticeable after a lag of about 10 h, and it reached a maximum at 16 h postrelease. The observation that release from both Gln-Ile deprivation and butyric acid treatment resulted in a similar kinetics of DNA synthesis suggests that the two procedures arrested cells at a similar point within the GO/Gl phase. Moreover, analysis by flow microfluorometry of cell DNA content after staining with propidium iodide indicated that over 90% of cells treated with either butyric acid or Gln-Ile deprivation were at the GO/Gl phase of the cell cycle (data not shown). It was evident from the results presented in Fig. 2B that MMuLV production was differentially affected by the two arrest procedures. MMuLV production was similar during arrest and release from butyric acid treatment. Although cultures deprived of Gln-Ile produced no virus, a gradual resumption of MMuLV production was noticed concomitant with the progression toward the S phase of the cell cycle. The results presented in Fig. 1 and 2 suggest that the specific treatment, rather than cell arrest at the GO/Gl phase, affects MMuLV production in the chronically infected cells. It is possible, however, that since butyric acid has multiple effects on the cell (for review, see reference 15), it eliminates a block on MMuLV production such as the one imposed during cell arrest. To explore this possibility, cells were first arrested by Gln-Ile deprivation and then treated with increasing concentrations of butyric acid (prepared in MEM-E without amino acid addition) (Fig. 3) . Cultures under such a double block treatment did not synthesize DNA (data not shown). Although the Gln-Ile-deprived cultures released no virus, the addition of butyric acid relieved the block. Maxi- Butyric acid (mM' mal MMuLV production was obtained after the Gln-Ile-deprived cultures were treated with 5 mM butyric acid (Fig. 3) . In this experiment, the control cultures produced relatively high amounts of MMuLV, and butyric acid did not affect the production. In other experiments (for example, see butyric acid, the medium was replaced with fresh medium containing the same components (IFN and butyric acid), and incubation was continued for an additional 18 h. The final medium was collected, and MMuLV production was determined by measuring reverse transcriptase activity. MMuLV production in control cultures without IFN (100% activity) was 21,000 cpm/106 cells. cells were pretreated with IFN, and after 24 h, butyric acid was added to IFN-containing medium for a further incubation of 24 h. Although virus production was inhibited by IFN, the subsequent addition of butyric acid restored MMuLV production to the level of control or butyric acidtreated cells (Table 1 ). This experiment indicated that butyric acid interfered with the maintenance of the antiviral (MMuLV) state induced by IFN.
We then investigated whether the establishment of the anti-MuLV state by IFN was also affected by butyric acid. Cells were pretreated with butyric acid (5 mM), and after 24 h, increasing concentrations of IFN were added for a further incubation of 24 h (Fig. 4) . Whereas in the control cells, 50 U of IFN per ml inhibited MMuLV production by 45%, in cultures pretreated with butyric acid, there was no inhibition of MMuLV at this IFN concentration. Higher concentrations of IFN induced stronger inhibitions, and pretreatment with butyric acid partially restored virus production (Fig. 4) . Thus, butyric acid treatment appears to overcome the inhibition of MMuLV production caused by two completely different treatments, namely, IFN and Gln-Ile deprivation.
Analysis of MMuLV budding and release. IFN has been shown to inhibit a late stage of MMuLV replication, at the budding or release of virions from the cell surface, resulting in virion accumulation on the cell surface (1, 9, 25) . It was of interest to investigate whether Gln-Ile deprivation similarly affected virus maturation. To this end, we developed a simple procedure to quantitatively assess MMuLV bound to the cell surface after the various treatments. The procedure is based on an electron microscopic observation that trypsin treatment strips the surface of chronically infected cells of bound MMuLV particles (T. Damci and A. Panet, unpublished data). Virions removed from the cell by trypsin treatment were concentrated and assayed for reverse transcriptase activity. To ascertain whether virions were quantitatively removed from the cell surface under experimental conditions (Table 2) , the trypsinization treatment was repeated. The trypsin-treated cells were pelleted, suspended, and again subjected to the enzyme. Only a small amount of virions was recovered after the second trypsin treatment (20% of the amount recovered after the first treatment; data not shown). The ratio of the reverse transcriptase-associated virions recovered from the cell surface to that recovered from the growth medium is a measurement of the release step. The results (Table 2) indicate that similar amounts of virions were dissociated by trypsin treatment from control, IFN-treated, or butyric acid-treated cells. However, very little, if any, MMuLV could be recovered from the surface of Gln-Ile-deprived cells. Thus, production of MMuLV in cultures deprived of Gln-Ile appears to be blocked before virion budding at the cell surface. On the other hand, in IFN-treated cells, virions were present on the surface, and release to the medium was inhibited.
In all of the experiments described above, MMuLV production was estimated from the amount of reverse transcriptase enzyme released to the medium. To eliminate the possibility that Gln-Ile-deprived cells produced virions deficient of reverse transcriptase activity, MMuLV was meta-12 3 bolically radiolabeled with [35S]methionine. The radiolabeled virions recovered from the growth medium were analyzed for the major viral protein (p30) by electrophoresis in sodium dodecyl sulfate-polyacrylamide gels (Fig. 5) . Media taken from the control and butyric acid-treated cells contained similar amounts of p30-associated virions (Fig. 5,  compare lanes 1 and 4) , IFN-treated cells released very little p30 (lane 2), and Gln-Ile-deprived cells released none (lane 3). These results are in accord with the analysis of reverse transcriptase-associated virions (Fig. 2) . Since after centrifugation (100,000 x g), the pellets of the growth medium contained radiolabeled cellular debris in addition to virions, cell proteins are also noticeable in the autoradiogram.
MMuLV protein synthesis. The results (Table 2) suggest that Gln-Ile deprivation blocked an earlier event in the production of MMuLV than that blocked by IFN. To investigate the effect of these treatments on viral protein synthesis and processing, cells were pulse-labeled with [35S]methionine, and extracts were subjected to immunoprecipitation (Fig. 6) . The Gln-Ile-deprived cells incorporated about 50% of the [35S]methionine incorporated by the other three cultures during a 1-h pulse. To quantitate the synthesis of viral proteins, equal amounts of radioactive extract were taken for the immunoprecipitations. Our antiserum for MMuLV immunoprecipitated primarily the precursor for gp7O and pl5E (Pre80env) (Fig. 6A) . The rate of Pre8Oenl' synthesis was very similar after the treatments which had no effect on MMuLV production (Fig. 6A, lanes 1 and 4) and after treatments which suppressed the virus (lanes 2 and 3) .
To follow synthesis of the gag gene product (Pre65gag), immunoprecipitations were carried out with antiserum directed to purified p30 (Fig. 6B) . The amounts of Pre65gag produced by the four cultures after 1 h of pulse labeling were very similar (Fig. 6B, lanes 1-4) . However, generation of p30 after a 1-h pulse of the Gln-Ile-deprived cells appeared to be very poor (Fig. 6B, lane 3) . The observation that processing of Pre65rar into p30 is blocked in the Gln-Ile-deprived cells was documented even better in a pulse-chase experiment (Fig. 6B, lane 3) . In the control, IFN-treated, or butyric acid-treated cells, 60 min of chase with excess methionine resulted in a complete conversion of Pre65rar to p30 (Fig.  6B, lanes 1, 2, and 4) . There was no apparent cleavage of Pre65rar in the Gln-Ile-deprived cells after 60 min of chase. These findings indicate that although both IFN treatment and Gln-Ile deprivation inhibited MMuLV at a relatively late step of replication, Gln-Ile deprivation interfered with an earlier step, during processing of the gag gene product.
DISCUSSION
In this communication, we described the effects of two selected treatments, which arrest cells at the GO/Gl phase, on MMuLV replication. The two methods, namely butyric acid treatment (6, 7) and Gln-Ile deprivation (32), synchronized over 95% of the cells at an apparently similar point of the GO/Gl phase. However, their influence on MMuLV production differed markedly. Gln-Ile deprivation completely blocked virus production, whereas butyric acid either had no effect on or even enhanced MMuLV production. This is the first documentation that MuLV can be efficiently produced by nonproliferating chronically infected cells. In the chicken system, it has previously been shown that cells arrested in a medium depleted of growth factors continued to release avian leukosis virus (4, 12) .
Why do butyric acid-arrested cells continue to produce MMuLV? One possibility is that butyric acid arrests the cells at a point of the GO/Gl phase that is close to but distinct from that of Gln-Ile deprivation or serum starvation. At this presumed point in the GO/Gl phase, MuLV may be produced in the absence of cell proliferation. It should be noted, however, that during cell proliferation, MuLV is produced predominantly during the M phase (3, 19, 20, 23 We have shown in this work that, whereas IFN treatment resulted in the accumulation of virions on the cell surface, deprivation of Gln-Ile inhibited MMuLV at an earlier step. Virus replication blocked at this step cannot be released after exposure to trypsin. Neither Gln-Ile deprivation nor IRN treatment had any effect on the synthesis of the polyprotein products of the gag and env genes. However, in the Gln-Ile-deprived cells, the processing of Pre65gag was aborted.
The protease responsible for the cleavage of MuLV PreO5gag has not yet been identified. Recent reports suggest that such a protease may be encoded at the 5' end of the MMuLV pol gene (17, 26) . Whatever the origin of the protease in MuLV-infected cells may be, it is not functional after deprivation of Gln-Ile. It is possible that the block in the processing of Pre65gag is coupled with the inhibition of MMuLV budding to the cell surface. Several conditional mutants of MuLV (R-ts24 and M-ts3) have been isolated, with an apparent defect in the processing of Pre65gag at the nonpermissive temperature (18, 28) . At high temperatures, these mutant viruses do not bud. The lesion in these mutants appears to involve a proteolytic reaction, since trypsin treatment at the nonpermissive temperature results in the processing of Pre65gag concomitant with budding and release of the mature virus (30) . Clearly, the block in the Gln-Iledeprived cells is at a different level, since trypsin treatment does not induce the budding and release of MMuLV. Thus, this block must affect a stage in virion assembly which is distinct from the function inhibited in the temperature-sensitive mutants, R-ts24 and M-ts3 (18, 28) , or after IFN treatment (1, 9, 25) .
